Emerging Treatment Options for Cervical Dysplasia and Early Cervical Cancer.
Michelle Boisen, Richard Guido
https://pubmed.ncbi.nlm.nih.gov/37650664/Actively Recruiting
Led by GOG Foundation · Updated on 2026-07-30
840
Participants Needed
156
Research Sites
52 weeks
Total Duration
Researchers are conducting a randomized controlled trial to compare survival outcomes between robotic-assisted laparoscopy and open hysterectomy with lymph node assessment for early-stage cervical cancer. The study aims to determine if robotic hysterectomy with tumor containment before colpotomy is not worse than abdominal hysterectomy in terms of disease-free survival. It includes patients with specific cervical cancer stages and tumor sizes suitable for surgery. Participants will undergo either a radical or simple hysterectomy using either traditional open surgery or a robotic-assisted technique. In the robotic group, the vagina is closed before colpotomy, and certain vaginal manipulators are not allowed. Both groups may have salpingectomy and oophorectomy with or without ovarian transposition. Surgeons will document operative details, including any complications, blood loss, and reasons for conversion to open surgery. During the trial, participants will be closely monitored with preoperative assessments like labs, EKG, and MRI to confirm eligibility. Surgical findings and complications will be recorded. The primary outcome measured is survival at 36 months. Participants must provide informed consent and undergo follow-up to assess disease status and survival over the study period, which extends until 2030.
CONDITIONS
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
S
Sarin Chhab
S
Shanon Matkin
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
GOG Foundation
Lead Sponsor
Intuitive Foundation
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Robotic hysterectomy (da Vinci) | Open hysterectomy (abdominal) | Standard open hysterectomy (current practice) |
|---|---|---|---|
| What it is | Minimally invasive robotic‑assisted radical or simple hysterectomy using the da Vinci system | Traditional abdominal radical or simple hysterectomy | Open radical hysterectomy is the guideline‑recommended surgical standard for early‑stage cervical cancer |
| Role in trial | Investigational arm assigned by randomization | Control arm assigned by randomization | Represents usual surgical approach outside trial |
| Primary use | Surgical removal of the uterus and surrounding tissues in early‑stage cervical cancer | Surgical removal of the uterus and surrounding tissues in early‑stage cervical cancer | Standard surgical treatment for early‑stage cervical cancer according to guidelines |
| How it is given or performed | Performed using a robotic surgical platform | Performed through an open abdominal incision | Typically performed via abdominal incision as standard practice |
| Evidence status | Effectiveness compared in trial; results pending | Effectiveness compared in trial; results pending | Supported by guidelines as current practice; lower perioperative blood loss and shorter hospital stay reported in some studies |
| Important risks | Surgical risks inherent to hysterectomy; minimally invasive safety unresolved pending trial results | Surgical risks inherent to open abdominal surgery | Known risks associated with open surgery based on long‑standing practice |
| Important limitations | Long‑term survival outcomes compared with open surgery are not yet available | Long‑term comparison outcomes awaiting results | Minimally invasive approaches remain controversial due to prior survival signal concerns |
| Patient impact | Potential for lower blood loss and shorter hospital stay | Open surgery associated with higher blood loss and longer stay in some comparisons | Represents familiar surgical recovery expectations |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Single surgical procedure
Participants undergo either robotic-assisted or open radical or simple hysterectomy surgery.
Duration - 36 months
Participants are monitored for disease-free survival and recovery for 36 months after surgery.
Regular follow-up visits
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Michelle Boisen, Richard Guido
https://pubmed.ncbi.nlm.nih.gov/37650664/Mario M Leitao, Kristin L Bixel, Dana Meredith Chase...
https://pubmed.ncbi.nlm.nih.gov/40188007/GOG Foundation
Lead Sponsor
Intuitive Foundation
Collaborating Sponsor